Literature DB >> 7025368

Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients.

G Opelz, B Graver, M R Mickey, P I Terasaki.   

Abstract

A series of 737 hemodialysis patients were studied for the relationship between lymphocytotoxic antibody formation and blood transfusions; 331 thereof were studied prospectively. With up to 20 transfusions, highly reactive (greater than 90% reactivity against random panel) antibodies were not found in any of the prospectively studied males or females without previous pregnancies. Nearly 90% of the males failed to form antibodies against greater than 10% of the panel donors. Patients with previous pregnancies developed antibodies at a much higher rate. Among 316 patients tested, antibodies against B cells were found more frequently than antibodies against T cells. Both T and B cell antibody levels often decreased in spite of additional transfusions. It is concluded that the risk of rendering a patient untransplantable because of sensitization as a result of transfusions is very small.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025368     DOI: 10.1097/00007890-198109000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts.

Authors:  T Furuya; N Murase; K Nakamura; J Woo; S Todo; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

Review 2.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Intraoperative red blood cell transfusion, delayed graft function, and infection after kidney transplant: an observational cohort study.

Authors:  Michael Mazzeffi; Srikar Jonna; Natalia Blanco; Orestes Mavrothalassitis; Obi Odekwu; Magali Fontaine; Peter Rock; Kenichi Tanaka; Kerri Thom
Journal:  J Anesth       Date:  2018-03-20       Impact factor: 2.078

4.  Sensitization from transfusion in patients awaiting primary kidney transplant.

Authors:  Julie M Yabu; Matthew W Anderson; Deborah Kim; Brian D Bradbury; Calvin D Lou; Jeffrey Petersen; Jerome Rossert; Glenn M Chertow; Dolly B Tyan
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

Review 5.  Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.

Authors:  Bradley A Warady; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

Review 6.  The generation and maintenance of serum alloantibody.

Authors:  M R Clatworthy; M Espeli; N Torpey; K G C Smith
Journal:  Curr Opin Immunol       Date:  2010-10       Impact factor: 7.486

Review 7.  Blood transfusion effects in kidney transplantation.

Authors:  C B Carpenter
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct

Review 8.  Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents.

Authors:  Nicole Brenner; Anuhya Kommalapati; Muhammad Ahsan; Anirban Ganguli
Journal:  J Nephrol       Date:  2019-11-28       Impact factor: 3.902

9.  Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events.

Authors:  Nataša Katalinić; Alma Starčević; Martina Mavrinac; Sanja Balen
Journal:  Clin Kidney J       Date:  2017-07-25

10.  Chapter 4: Red cell transfusion to treat anemia in CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.